Menu
1-702-720-6310 info@microcapspecualtors.com

Hopes — And Questions — Are Raised By Study Of French Biotech’s ALS Drug – Forbes


Forbes

Hopes — And Questions — Are Raised By Study Of French Biotech’s ALS Drug
Forbes
A new drug developed by a small French biotechnology company appears to slow amyotrophic lateral sclerosis, or ALS, by 27%, providing another new weapon against the deadly neurodegenerative disease, two weeks after the U.S. Food and Drug …

Search